These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28710503)

  • 1. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
    Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
    Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
    Henninger C; Huelsenbeck S; Wenzel P; Brand M; Huelsenbeck J; Schad A; Fritz G
    Pharmacol Res; 2015 Jan; 91():47-56. PubMed ID: 25462173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42.
    Kücük P; Abbey L; Schmitt J; Henninger C; Fritz G
    Pharmacol Res; 2024 May; 203():107165. PubMed ID: 38561112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity.
    Huelsenbeck J; Henninger C; Schad A; Lackner KJ; Kaina B; Fritz G
    Cell Death Dis; 2011 Aug; 2(8):e190. PubMed ID: 21833028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct contribution of Rac1 expression in cardiomyocytes to anthracycline-induced cardiac injury.
    Henninger C; Pohlmann S; Ziegler V; Ohlig J; Schmitt J; Fritz G
    Biochem Pharmacol; 2019 Jun; 164():82-93. PubMed ID: 30936017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity.
    Henninger C; Huelsenbeck J; Huelsenbeck S; Grösch S; Schad A; Lackner KJ; Kaina B; Fritz G
    Toxicol Appl Pharmacol; 2012 May; 261(1):66-73. PubMed ID: 22712078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.
    Yoshida M; Shiojima I; Ikeda H; Komuro I
    J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rac1 contributes to cerebral ischemia reperfusion-induced injury in mice by regulation of Notch2.
    Meng S; Su Z; Liu Z; Wang N; Wang Z
    Neuroscience; 2015 Oct; 306():100-14. PubMed ID: 26299339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac1 modulates acute and subacute genotoxin-induced hepatic stress responses, fibrosis and liver aging.
    Bopp A; Wartlick F; Henninger C; Kaina B; Fritz G
    Cell Death Dis; 2013 Mar; 4(3):e558. PubMed ID: 23519127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSC23766, a Known Inhibitor of Tiam1-Rac1 Signaling Module, Prevents the Onset of Type 1 Diabetes in the NOD Mouse Model.
    Veluthakal R; Sidarala V; Kowluru A
    Cell Physiol Biochem; 2016; 39(2):760-7. PubMed ID: 27467102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
    Lenčová-Popelová O; Jansová H; Jirkovský E; Bureš J; Jirkovská-Vávrová A; Mazurová Y; Reimerová P; Vostatková L; Adamcová M; Hroch M; Pokorná Z; Kovaříková P; Šimůnek T; Štěrba M
    Toxicology; 2016 Nov; 372():52-63. PubMed ID: 27816693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.
    Rea D; Coppola C; Barbieri A; Monti MG; Misso G; Palma G; Bimonte S; Zarone MR; Luciano A; Liccardo D; Maiolino P; Cittadini A; Ciliberto G; Arra C; Maurea N
    In Vivo; 2016; 30(3):279-90. PubMed ID: 27107087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1.
    Willis MS; Parry TL; Brown DI; Mota RI; Huang W; Beak JY; Sola M; Zhou C; Hicks ST; Caughey MC; D'Agostino RB; Jordan J; Hundley WG; Jensen BC
    Circ Heart Fail; 2019 Mar; 12(3):e005234. PubMed ID: 30871347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for
    Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
    Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cardenolide Glycoside Acovenoside A Affords Protective Activity in Doxorubicin-Induced Cardiotoxicity in Mice.
    Ezzat SM; El Gaafary M; El Sayed AM; Sabry OM; Ali ZY; Hafner S; Schmiech M; Jin L; Syrovets T; Simmet T
    J Pharmacol Exp Ther; 2016 Aug; 358(2):262-70. PubMed ID: 27247000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.
    Antoniak S; Tatsumi K; Schmedes CM; Grover SP; Pawlinski R; Mackman N
    J Mol Cell Cardiol; 2018 Sep; 122():80-87. PubMed ID: 30098988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented Rac1 Expression and Activity are Associated with Oxidative Stress and Decline of β Cell Function in Obesity.
    Zhou S; Yu D; Ning S; Zhang H; Jiang L; He L; Li M; Sun M
    Cell Physiol Biochem; 2015; 35(6):2135-48. PubMed ID: 25896148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinochrome D Attenuates Doxorubicin-Induced Cardiomyocyte Death via Improving Glutathione Metabolism and Attenuating Oxidative Stress.
    Yoon CS; Kim HK; Mishchenko NP; Vasileva EA; Fedoreyev SA; Stonik VA; Han J
    Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30577438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin protects keratinocytes from DNA damage-related pro-apoptotic stress responses stimulated by anticancer therapeutics.
    Ziegler V; Albers A; Fritz G
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1082-92. PubMed ID: 26876155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.